Market Sensitive News

Primal Pet Foods Recalls Raw Frozen Patties Beef Formula

FDA Says Pharmacists Can Prescribe Pfizer COVID-19 Pill Paxlovid

Walmart+ Adds InHome Delivery Service As Option

Mylan Pharma Recalls Unbranded Insulin Glargine Injection Pens

Huobi Set To Expand Crypto-related Business To The U.S.

Wall Street Poised To Open In The Red

Ben & Jerry's Sues Parent Unilever To Block Sale Of Israeli Unit

Lavender Shortbread Cookies Sold At Target Recalled

Biden To Award Medal Of Honor To 4 Vietnam War Veterans

Futures Point To Lower Open For Wall Street

Highland Park Shooting Suspect In Custody

Listeria Outbreak Linked To Big Olaf Creamery Ice Cream: CDC

European Parliament Passes Important Laws For Online Platforms

Ben & Jerry's Sues Parent Unilever To Block Sale Of Israeli Unit

Recession Fears And Dollar Strength Drag Crypto Markets

Australia Home Loans Rise 2.1% On Month In May

Holcim To Buy Privately Held Belgian Firm Cantillana For Undisclosed Sum

Syros Pharmaceuticals To Acquire TYME Technologies

Australia Trade Data Due On Thursday

Cowen Rallies On Reports Of Possible Acquisition

Novavax's Nuvaxovid COVID-19 Vaccine Conditionally Authorized In EU For Adolescents Aged 12 To 17

Tesla To Recall 59,000 Vehicles On Software Glitch

Highland Park Shooting Suspect In Custody

Australia Building Approvals Jump 9.9% On Month In May

Numis Says Q3 Trading Strong, FY22 Outlook In-line With Market View; Stock Up

Battery Maker Northvolt Raises $1.1 Bln Funding

AstraZeneca To Acquire TeneoTwo And Its T-cell Engager

Australian Market Sharply Higher

Listeria Outbreak Linked To Big Olaf Creamery Ice Cream: CDC

Drake Returns To No. 1 On Billboard Artist 100

U.S. Dollar Showing Strength Against Most Majors

Rivian Automotive Stock Gains 8% On Q2 Production Results

The Smile's Debut Album Reaches Top 10 On Multiple Billboard Charts

Schneider Electric, Rexel, Legrand Confirm Statement Of Objection From Competition Authority

Babyface Signs With Capitol Records, Announces New Album 'Girls' Night Out'

Vertex Pharma Says FDA Lifts Clinical Hold On Phase 1/2 Trial Of VX-880 To Treat Type 1 Diabetes